CYSB2300217 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-11-29 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
JYSB2200033 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-02-28 | | Novo Nordisk A/S | | | view |
CYSB2101240 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2021-10-27 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
JYSZ2100524 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | License Renew | 2021-07-21 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
CYSB2200289 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-12-27 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
CXSS2101010 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.4) | New Drug Application | 2021-07-13 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
CXSS2200007 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2022-01-26 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
JYSZ2100523 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | License Renew | 2021-07-21 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
CYSB2400217 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-08-14 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
JYSB2200032 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-02-28 | | Novo Nordisk A/S | | | view |
JYSB1200180 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2012-07-13 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2014-03-13 | view |
JXSL0600021 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Import Drug Application | 2006-04-11 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2007-05-21 | view |
JYSB1700129 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2017-07-06 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-10-30 | view |
JYSB2000365 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(1) | Supplementary Application | 2020-08-07 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-08-17 | view |
JYSB1200181 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2012-07-13 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2014-03-13 | view |
JYSB2000364 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(1) | Supplementary Application | 2020-08-07 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-08-17 | view |
JXSS0900007 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Import Drug Application | 2009-08-05 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2012-02-20 | view |
JYSB1700144 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2017-08-21 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-09-27 | view |
JXSS0900008 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Import Drug Application | 2009-08-05 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2012-02-20 | view |
JYSB1700128 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2017-07-06 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-10-30 | view |